These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37620764)

  • 1. Impact of signs and symptoms on the prognosis of patients with HFmrEF.
    Liu Z; Zhu Y; Zhang L; Wu M; Huang H; Peng K; Zhao W; Chen S; Peng X; Li N; Zhang H; Zhou Y; Chen Y; Xiao S; Yi L; Fan J; Zeng J
    BMC Cardiovasc Disord; 2023 Aug; 23(1):420. PubMed ID: 37620764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and Treatment Strategies for Atrial Fibrillation in Heart Failure with Mildly Reduced Ejection Fraction.
    Schupp T; Schmitt A; Reinhardt M; Abel N; Lau F; Abumayyaleh M; Dudda J; Weidner K; Ayoub M; Akin M; Müller J; Akin I; Behnes M
    Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38825871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk.
    Miller RJH; Nabipoor M; Youngson E; Kotrri G; Fine NM; Howlett JG; Paterson ID; Ezekowitz J; McAlister FA
    ESC Heart Fail; 2022 Jun; 9(3):1564-1573. PubMed ID: 35261203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of acute decompensated heart failure in patients with heart failure with mildly reduced ejection fraction.
    Schmitt A; Schupp T; Reinhardt M; Abel N; Lau F; Forner J; Ayoub M; Mashayekhi K; Weiß C; Akin I; Behnes M
    Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(2):225-241. PubMed ID: 37950915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry.
    Hao C; Luo J; Liu B; Xu W; Li Z; Gong M; Qin X; Shi B; Wei Y
    Clin Interv Aging; 2022; 17():479-493. PubMed ID: 35444413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
    Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
    Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
    Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of different types of heart failure on long-term renal prognosis in patients with renal insufficiency and heart failure].
    Wang YC; Ye N; Bian WJ; Cheng H
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 39(1):1-7. PubMed ID: 36776008
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.
    Beles M; Masuy I; Verstreken S; Bartunek J; Dierckx R; Heggermont W; Oeste C; De Boeck M; Fovel I; Maris M; Vermeulen Z; Vanderheyden M
    ESC Heart Fail; 2023 Aug; 10(4):2269-2280. PubMed ID: 37095712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.
    Lau F; Schupp T; Schmitt A; Reinhardt M; Abel N; Abumayyaleh M; Weidner K; Duerschmied D; Ayoub M; Mashayekhi K; Akin M; Ayasse N; Akin I; Behnes M
    Respir Med; 2024 Mar; 223():107536. PubMed ID: 38272377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection Fraction.
    Schmitt A; Behnes M; Rusnak J; Akin M; Reinhardt M; Abel N; Forner J; Müller J; Weidner K; Abumayyaleh M; Akin I; Schupp T
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731194
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of diastolic dysfunction on outcome in heart failure patients with mid-range or reduced ejection fraction.
    Liu D; Hu K; Lau K; Kiwitz T; Robitzkat K; Hammel C; Lengenfelder BD; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2021 Aug; 8(4):2802-2815. PubMed ID: 33932134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in patients with heart failure and mildly reduced left ventricular ejection fraction.
    Liu Z; Zhu Y; Chen S; Wu M; Huang H; Peng K; Zhang L; Zhao W; Peng X; Li N; Zhang H; Zhou Y; Peng Y; Fan J; Zeng J
    Sci Rep; 2023 Apr; 13(1):6832. PubMed ID: 37100821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of short-term, intermediate-term, and long-term cardiac events in patients hospitalized for HFmrEF.
    Zhu Y; Peng X; Wu M; Huang H; Li N; Chen Y; Xiao S; Zhang H; Zhou Y; Chen S; Liu Z; Yi L; Peng Y; Fan J; Zeng J
    ESC Heart Fail; 2022 Oct; 9(5):3124-3138. PubMed ID: 35751458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.